Lucier Brushes Off Integration Worries in Merger with ABI | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen Chairman and CEO Greg Lucier, who will hold the same role with Applied Biosystems if the firms consummate their $6.7 billion merger later this year, yesterday brushed aside concerns about integrating the two large firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.